b.nilsen

TL2 Moderator · Kristiansand

Contributes reviews on supplier material. Based in Kristiansand.

Joined 19 March 2025 · last posted 2d

66 posts, newest first. Showing up to 150.

Journal club: what we got wrong in an earlier session Replied, post #121 · Evidence › Journal club · 25 Jul 2026 · 13 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
Reading a home test result without over-claiming Replied, post #124 · Analytics › Home & field testing · 18 Jul 2026 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Revisiting: The best-written scientific paper you have read Replied, post #97 · Lounge › Off topic · 17 Jul 2026 · 0 likes Worth separating two things that post #93 runs together. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #54 · Practice › Side effects · 16 Jul 2026 · 0 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
What is genuinely unknown about long-term amylin agonism Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 14 Jul 2026 · 0 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
Pooling trials with different estimands Replied, post #83 · Evidence › Meta-analyses · 9 Jul 2026 · 31 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
Coming back to: Time to steady state after a dose increase Replied, post #77 · Pharmacology › Pharmacokinetics · 15 Jun 2026 · 1 like Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
Follow-up: Prior authorisation: what the criteria usually require Replied, post #16 · Access › Insurance & coverage · 11 Jun 2026 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #51 · Analytics › HPLC & UHPLC · 31 May 2026 · 4 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
Second pass at: Metformin co-administration and additive GI effects Replied, post #88 · Practice › Interactions · 19 Apr 2026 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #19 · Devices › Syringes & needles · 9 Apr 2026 · 1 like On post #15 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #65 · Practice › Side effects · 6 Apr 2026 · 3 likes Coming back to post #63, because the follow-up matters more than the original answer. Nausea: the most common side effect and the most dose- and titration-dependent…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #129 · Access › Pricing · 28 Mar 2026 · 0 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
Second pass at: Identical chromatograms across two different lots Replied, post #94 · Sourcing › Red flags · 25 Mar 2026 · 16 likes post #93 answers the question as asked. The question underneath it is different. Inconsistency across documents: a certificate stating one purity, a website claiming…
Second pass at: Identical chromatograms across two different lots Replied, post #77 · Sourcing › Red flags · 19 Mar 2026 · 0 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Second pass at: When your prescriber and the evidence disagree Started this topic · Clinical › Prescriber conversations · 11 Mar 2026 · 11 likes Second pass at: When your prescriber and the evidence disagree — setting out what I have, and where I think it stops being reliable. General question, not a request for…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #105 · Compounds › Oral incretins · 25 Feb 2026 · 2 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
Research-use-only labelling: what it means and what it does not Replied, post #96 · Sourcing › Regulatory · 1 Feb 2026 · 5 likes Picking up post #93: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Reconstitution volumes that produce round numbers, tabulated Replied, post #32 · Practice › Reconstitution · 25 Jan 2026 · 8 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #79 · Wellbeing › Mental health · 19 Jan 2026 · 13 likes This follows post #76 rather than contradicting it. Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be…
Named, unnamed and unspecified impurities as regulatory categories Replied, post #4 · Analytics › Impurities & related substances · 13 Jan 2026 · 1 like On the opening post — agreed on the reasoning, with one qualification. Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #24 · Regional › UK & Ireland · 30 Dec 2025 · 0 likes Picking up post #21: that is the part I would want checked first. Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only.…
Request: a diff view for wiki revisions — the long version Replied, post #91 · Meta › Feature requests · 29 Dec 2025 · 0 likes Coming back to post #89, because the follow-up matters more than the original answer. Alternatives: if you have thought of a way the current site might already serve…
Micro-titration: a disputed topic, argued properly Replied, post #8 · Practice › Dosing & titration · 2 Dec 2025 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Run-in periods and the population they select Replied, post #24 · Evidence › Trials · 19 Nov 2025 · 8 likes Coming back to post #22, because the follow-up matters more than the original answer. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
DXA precision and the least significant change for lean mass Replied, post #7 · Outcomes › Body composition · 18 Nov 2025 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Lyophilisation and why the cake looks the way it does Replied, post #21 · Pharmacology › Formulation chemistry · 20 Oct 2025 · 23 likes This follows post #18 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
How to ask about something you suspect is a bad idea Replied, post #16 · Start Here › How to Ask · 14 Oct 2025 · 3 likes I read post #14 twice before replying, because I had assumed the opposite. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #95 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 5 likes This follows post #92 rather than contradicting it. Cagrilintide alone is discussed less than in combination because the published data is almost entirely from…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #34 · Compounds › Tirzepatide · 2 Oct 2025 · 3 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #85 · Evidence › Preprints · 2 Oct 2025 · 3 likes Worth separating two things that post #81 runs together. Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That…
Second pass at: Programming during a large energy deficit Replied, post #11 · Nutrition & Training › Resistance training · 18 Sep 2025 · 32 likes On post #7 — agreed on the reasoning, with one qualification. Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance…
Washout: how long is long enough, and for what purpose Replied, post #67 · Pharmacology › Pharmacokinetics · 16 Sep 2025 · 6 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
Substitution between formats during a shortage Replied, post #47 · Access › Shortages · 29 Aug 2025 · 6 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #14 · Clinical › Special populations · 26 Aug 2025 · 7 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #44 · Start Here › How to Ask · 26 Aug 2025 · 22 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
What this community means by "a source", in practical terms Replied, post #80 · Start Here › Welcome · 21 Aug 2025 · 23 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
Titles that describe the question, not the situation Replied, post #76 · Start Here › How to Ask · 20 Aug 2025 · 15 likes On post #72 — agreed on the reasoning, with one qualification. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which…
A preprint whose numbers changed substantially at publication Replied, post #15 · Evidence › Preprints · 10 Aug 2025 · 25 likes Picking up post #12: that is the part I would want checked first. Discussing preprints in this community: bring them in for early discussion, label them clearly as…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #26 · Compounds › Repair & healing peptides · 3 Aug 2025 · 13 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #6 · Practice › Side effects · 26 Jul 2025 · 5 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
Coming back to: When "no data" is the complete and final answer Replied, post #58 · Compounds › Other compounds · 25 Jul 2025 · 0 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #40 · Evidence › Journal club · 14 Jul 2025 · 0 likes I read post #38 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
Anxiety in the first weeks: drug, situation, or both Replied, post #106 · Wellbeing › Mental health · 22 Jun 2025 · 10 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
Temperature loggers worth the money — the long version Replied, post #3 · Devices › Cold chain · 20 Jun 2025 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Temperature logging: devices that record temperature over time let you confirm cold…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #97 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 3 likes Picking up post #94: that is the part I would want checked first. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating…
[2026 update] An appeal that failed, and what I would do differently Replied, post #127 · Access › Insurance & coverage · 15 Jun 2025 · 31 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
Price changes over 2025 and 2026, tabulated and dated Replied, post #7 · Access › Pricing · 8 Jun 2025 · 21 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Trial registration and comparing the protocol with the paper Replied, post #12 · Evidence › Trials · 4 Jun 2025 · 24 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
A well-designed study with a badly written abstract Replied, post #120 · Evidence › Study critique · 31 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A claim built entirely on a subgroup analysis Replied, post #8 · Evidence › Study critique · 27 Apr 2025 · 21 likes Picking up post #5: that is the part I would want checked first. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad…
Coming back to: Why the cheapest option is often not the cheapest Replied, post #15 · Access › Pricing · 30 Mar 2025 · 4 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
Telehealth prescribing models in the US Replied, post #68 · Regional › North America · 9 Mar 2025 · 0 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
Research-use-only status: what it means legally and practically — a second dataset Replied, post #54 · Compounds › Other compounds · 2 Jan 2025 · 9 likes Worth separating two things that post #50 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #69 · Compounds › Semaglutide · 1 Jan 2025 · 3 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Promotion criteria, and the one that stops most nominations Replied, post #137 · Documentation › Doc review · 11 Dec 2024 · 12 likes On post #133 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #27 · Compounds › Secretagogues & GH axis · 7 Dec 2024 · 16 likes Worth separating two things that post #23 runs together. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a…
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #9 · Practice › Interactions · 20 Nov 2024 · 6 likes Worth separating two things that post #5 runs together. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #20 · Sourcing › Regulatory · 2 Nov 2024 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #111 · Clinical › Comorbidities · 27 Oct 2024 · 0 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
Irish differences from the UK position Replied, post #39 · Regional › UK & Ireland · 15 Oct 2024 · 3 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #106 · Access › Shortages · 13 Oct 2024 · 23 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #9 · Access › Shortages · 8 Oct 2024 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #57 · Clinical › Bloodwork · 26 Sep 2024 · 4 likes post #56 answers the question as asked. The question underneath it is different. A single value outside interval: usually uninformative on a single draw. What makes a…
Reporting a discrepancy without making an allegation Replied, post #40 · Sourcing › Vendor reports · 24 Aug 2024 · 16 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
Cold packs, phase-change material, and what survives ten days Replied, post #11 · Sourcing › Logistics · 13 Jun 2024 · 30 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…